Inventor
LU CHIN-CHUN
US14 patents
⚠️ This page may combine multiple inventors who share the name “LU CHIN-CHUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK & CO INC
9 patentsUS6316611B1Nov 13, 2001
Human N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses therefor
MERCK & CO INC12 citations81
US6521413B1Feb 18, 2003
Human N-methyl-D-aspartate receptor subnits, nucleic acids encoding same and uses therefor
MERCK & CO INC6 citations73
US6362316B1Mar 26, 2002
Human metabotropic glutamate receptor subtype mGluR6 protein
MERCK & CO INC5 citations73
US6956102B2Oct 18, 2005
Human N-methyl-D-aspartate receptor subunits nucleic acids encoding same and uses therefor
MERCK & CO INC1 citations62
US6864358B2Mar 8, 2005
Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor
MERCK & CO INC1 citations62
US6825322B2Nov 30, 2004
Human N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses therefor
MERCK & CO INC1 citations62
US6469142B1Oct 22, 2002
Human N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses therefor
MERCK & CO INC1 citations62
US6376660B1Apr 23, 2002
Human N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses therefor
MERCK & CO INC1 citations62
US6111091AAug 29, 2000
Human N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses therefore
MERCK & CO INC2 citations62
SIBIA NEUROSCIENCES INC
3 patentsUS5985586ANov 16, 1999
Methods for identifying compounds that modulate the activity of human N-methyl-D-aspartate receptors
SIBIA NEUROSCIENCES INC18 citations92
US5912122AJun 15, 1999
Nucleic acids encoding and method for detecting nucleic acid encoding human metabotropic glutamate receptor subtype mGluR6
SIBIA NEUROSCIENCES INC24 citations92
US5849895ADec 15, 1998
Human N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses therefor
SIBIA NEUROSCIENCES INC19 citations92
CELGENE CORP
2 patentsUS12486281B2Dec 2, 2025
Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith
CELGENE CORP0 citations56
US11306101B2Apr 19, 2022
Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith
CELGENE CORP0 citations56